Liberty One Investment Management, LLC Anavex Life Sciences Corp. Transaction History

Liberty One Investment Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 26, 2024	BUY	$5.04 - $9.95 $3,351 - $6,616	665 Added 4.49%	15,462 $143,000
Q3 2023 Nov 03, 2023	SELL	$6.55 - $9.37 $6,739 - $9,641	-1,029 Reduced 6.5%	14,797 $96,000
Q2 2023 Aug 04, 2023	BUY	$7.66 - $9.5 $22,221 - $27,559	2,901 Added 22.44%	15,826 $128,000
Q1 2023 May 15, 2023	SELL	$8.32 - $11.75 $3,727 - $5,264	-448 Reduced 3.35%	12,925 $110,000
Q4 2022 Feb 15, 2023	SELL	$7.65 - $14.43 $313 - $591	-41 Reduced 0.31%	13,373 $123,000
Q3 2022 Nov 16, 2022	BUY	$8.9 - $12.86 $119,384 - $172,504	13,414 New	13,414 $138,000
Q2 2022 Aug 01, 2022	SELL	$7.31 - $12.84 $95,899 - $168,447	-13,119 Closed	0 $0
Q1 2022 May 03, 2022	BUY	$9.74 - $17.69 $24,145 - $43,853	2,479 Added 23.3%	13,119 $161,000
Q4 2021 Jan 21, 2022	BUY	$16.88 - $23.31 $179,603 - $248,018	10,640 New	10,640 $184,000

152

26.5M

674K

811K

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $443M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

Get notified when there are updates to the investment portfolio of Liberty One Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Liberty One Investment Management, LLC with notifications on news.